Jordan L. GoldmanJordan L.Goldman

Guggenheim Investments, in connection with various equity investment matters.

Galway Sustainable Capital, in connection with its $250 million financing.

Orchestra BioMed, Inc., a biomedical innovation company, in connection with various corporate matters and transactions, including its $72 million Series B/B1 financings and its $110 million Series D financing

Annexus Health, Inc., in connection with its $33 million Series B financing and various corporate matters.

Clearview AI, a leading facial recognition company, in connection with its $30 million Series B financing and various corporate matters.

CurbWaste, in connection with its $10 million Series A financing and $28 million Series B financing.

Deerfield Management Company, in connection with various equity and debt investments and joint ventures.

RSE Ventures, the venture arm of Miami Dolphins owner and The Related Companies Chairman Stephen Ross, in connection with various transactions, including: its preferred equity investment in the Momofuku Restaurant Group; its preferred equity investment in the Fuku fast-casual restaurant chain; its preferred equity investment in Milk Bar; and its preferred equity investment in &pizza.

its preferred equity investment in the Momofuku Restaurant Group;

its preferred equity investment in the Fuku fast-casual restaurant chain;

its preferred equity investment in Milk Bar; and

its preferred equity investment in &pizza.

Digitalis Ventures, in connection with general corporate matters and various debt and equity investments.

Ascent Biomedical Ventures, in connection with various debt and minority equity investments.

Orchestra Medical Ventures, in connection with various debt and minority equity investments.

Nyca Partners, in connection with various equity investments.

Subversive Capital, in connection with various debt and equity investments.

Both companies and venture capital investors in various preferred stock financing rounds.

Various foreign companies in connection with U.S. investments.

Various early-stage startup companies in connection with general corporate matters and financing.

Semperis Technologies, a leading cybersecurity company, in its acquisition of MightyID.

Orchestra BioMed, Inc., a biomedical innovation company, in connection with various corporate matters and transactions, including its business combination agreement to merge with a special purpose acquisition company (SPAC).

Merck in a strategic collaboration with Amathus Therapeutics to develop novel small molecule therapeutic candidates for neurodegenerative diseases.

Elanco US Inc., a subsidiary of Eli Lilly and Company, in its acquisition of Boehringer Ingelheim Vetmedica’s U.S. feline, canine and rabies vaccines portfolio and Fort Dodge manufacturing and R&D site for approximately $885 million.

Merck in connection with its acquisition of Afferent Pharmaceuticals.

Formation counsel to Technicolor and Sony Corporation''s joint patent licensing program for digital television (DTV) and computer display monitor (CDM).